Biotech · Private company
Satsuma Pharmaceuticals, Inc.
Track this companyFree. Adds Satsuma Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- DihydroergotaminePhase 3 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- DihydroergotaminePhase 1 · Migraine With AuraClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigrainePHASE3 · COMPLETED · started Jun 30, 2021ClinicalTrials.gov NCT04940390 · fetched Nov 12, 2026
- A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy SubjectsPHASE1 · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT05337254 · fetched Nov 12, 2026
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of MigrainePHASE3 · COMPLETED · started Sep 14, 2020ClinicalTrials.gov NCT04406649 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of MigrainePHASE3 · COMPLETED · started Jun 24, 2019ClinicalTrials.gov NCT03901482 · fetched Nov 12, 2026
- A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy SubjectsPHASE1 · COMPLETED · started Sep 11, 2018ClinicalTrials.gov NCT03874832 · fetched Nov 12, 2026